ReportLinker
-
Madrigal Pharmaceuticals Sells $500M in Stocks in Prep for FDA Approval
Conshohocken-based Madrigal Pharmaceuticals is in a flurry of activity as it prepares for the potential launch of its NASH drug…
ReportLinker

Conshohocken-based Madrigal Pharmaceuticals is in a flurry of activity as it prepares for the potential launch of its NASH drug…